The Melbourne Consensus Statement on the early detection of prostate cancer

BJU Int. 2014 Feb;113(2):186-8. doi: 10.1111/bju.12556.


Various conflicting guidelines and recommendations about prostate cancer screening and early detection have left both clinicians and their patients quite confused. At the Prostate Cancer World Congress held in Melbourne in August 2013, a multidisciplinary group of the world's leading experts in this area gathered together and generated this set of consensus statements to bring some clarity to this confusion. The five consensus statements provide clear guidance for clinicians counselling their patients about the early detection of prostate cancer.

Keywords: PSA testing; guideline; prostate cancer; risk stratification; screening.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • Aged
  • Australia / epidemiology
  • Biomarkers, Tumor / blood*
  • Consensus
  • Decision Making
  • Digital Rectal Examination / statistics & numerical data*
  • Early Detection of Cancer / statistics & numerical data*
  • Humans
  • Male
  • Mass Screening / organization & administration*
  • Middle Aged
  • Practice Guidelines as Topic
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / prevention & control
  • Randomized Controlled Trials as Topic
  • Risk Factors


  • Biomarkers, Tumor
  • Prostate-Specific Antigen